|
J. Michael Ruppert, Ph.D. |
Professor
BA: West Virginia University, Morgantown, WV, 1983
MD: Johns Hopkins University, Baltimore, MD, 1990
PhD: Johns Hopkins University, Baltimore, MD, 1990Joined the faculty:
2008
Affiliations:
Mary Babb Randolph Cancer Center
Teaching: BMS 730
Office: 212 Byrd Biomedical Bldg.
Phone: (304) 293-5246
Fax: (304) 293-4667
Email:
mruppert@hsc.wvu.edu
|
|
|
|
Research Interests: |
|
|
|
Research Focus:
Initiation of epithelial cancers of the skin and breast;
signaling by KLF4 and Gli1
Research Interests:
In vitro models of epithelia; Mouse models of cancer;
Cell fate determination in epithelia; Sonic
Hedgehog-Gli1 pathway; KLF4/GKLF pathway; Breast cancer;
Non-melanoma skin cancer.
We focus on the role of the
zinc finger transcription factors KLF4/GKLF and Gli1 as
regulators of chromatin structure, gene transcription
and malignant transformation in epithelial cells, and
their role in tumors such as breast cancer and skin
cancer. These two oncogenes appear to function early in
the genesis of carcinoma (e.g., Gli1 in cutaneous basal
cell cancer, KLF4 in squamous cell carcinoma and breast
cancer). We use a parallel approach, analyzing an in
vitro epithelial model called RK3E cells,
tetracycline-inducible transgenic mouse models, and
tissues representing primary human tumors and normal
tissues.
In 1999 the laboratory
reported the first successful use of epithelial cells as
a host for oncogene isolation by a technique termed
expression cloning, where cDNA libraries are expressed
in an indicator line, and transforming oncogenes are
identified by their phenotype. This study and our
subsequent work identified KLF4 as a novel transcription
factor oncogene and a potentially early effector of
tumor initiation or progression in common adult cancers
such as squamous cell carcinoma (SCC) and others. KLF4
is now recognized as a major determinant of the
embryonic stem cell phenotype and may play a similar
role in cancer cells.
Subsequently we reported
that induction of KLF4 in the skin rapidly induces
lesions that resemble each of the stages of SCC tumor
progression, identifying KLF4 as a candidate tumor
initiator. Ongoing work in the lab includes analysis of
a post-translational mechanism that regulates KLF4
expression levels and analysis of small molecules that
specifically block KLF4 pathway activity in vitro and in
vivo (e.g., retinoids).
We have used microarrays in
combination with inducible expression of Gli1 for
functional analysis of the Hedgehog pathway,
demonstrating roles for Snail, E-cadherin, Wnt ligands,
b-catenin, mTOR and others as
downstream effectors of Gli1. We demonstrated that Gli1
switches b-catenin
from its role in normal cell adhesion to a role in cell
growth mediated by canonical Wnt signaling. |
|
|
|
References:
|
|
|
- Jiang W, Deng W,
Bailey SK, Nail CD, Frost AR, Brouillette WJ, Muccio
DD, Grubbs CJ, Ruppert JM, Lobo-Ruppert SM.
Prevention of KLF4-mediated tumor initiation and
malignant transformation by UAB30 rexinoid. Cancer
Biol. Ther 2009;8:285-94.
- Jiang W, Lobo-Ruppert
SM, Ruppert JM. Bad things happen in the basal
layer: KLF4 and squamous cell carcinoma. Cancer
Biol. Ther 2008;7(5):783-5. PM:18424916.
- Li, X., Deng, W.,
Lobo-Ruppert, S. M., and Ruppert, J. M. Gli1 acts
through Snail and E-cadherin to promote nuclear
signaling by β-catenin. Oncogene, 26: 4489-4498,
2007.
- Mukherjee S,
Frolova N, Sadlonova A, Novak Z, Steg A, Page GP,
Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson MR
and Frost AR. Hedgehog signaling and response to
cyclopamine differs in epithelial and stromal cells
in benign breast and breast cancer. Cancer Biology
and Therapy 5: 674-83, 2006.
- Li X, Deng W, Nail
CD, Bailey SK, Kraus MH, Ruppert JM, and Lobo-Ruppert
SM. Snail induction is an early response to Gli1
that determines the efficiency of epithelial
transformation. Oncogene 25: 609-21, 2006.
- Huang C C, Liu Z,
Li X, Bailey SK, Nail CD, Foster, KW, Frost, AR,
Ruppert, JM, and Lobo-Ruppert, SM. KLF4 and PCNA
identify stages of tumor initiation in a conditional
model of cutaneous squamous epithelial neoplasia.
Cancer Biology and Therapy, 4: 1401-1408, 2005.
- Foster KW, Liu Z,
Nail CD, Li X, Fitzgerald TJ, Bailey SK, Frost AR,
Louro ID, Townes TM, Paterson AJ, Kudlow JE, Lobo-Ruppert
SM, and Ruppert JM. Induction of KLF4 in basal
keratinocytes blocks the
proliferation-differentiation switch and initiates
squamous epithelial dysplasia. Oncogene 24:
1491-1500, 2005.
|
|